These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23706224)

  • 21. Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.
    Anderson RB; Cianciolo GJ; Kennedy MN; Pizzo SV
    J Leukoc Biol; 2008 Feb; 83(2):381-92. PubMed ID: 17967834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes.
    Erikçi E; Gursel M; Gürsel I
    Biomaterials; 2011 Feb; 32(6):1715-23. PubMed ID: 21112627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B.
    Li N; Fan XG; Chen ZH; Huang Y; Quan J; Liu ZB
    APMIS; 2005 Oct; 113(10):647-54. PubMed ID: 16309422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E; Berg M; Magnusson M
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9.
    Liu J; Xu C; Liu YL; Matsuo H; Hsieh RP; Lo JF; Tseng PH; Yuan CJ; Luo Y; Xiang R; Chuang TH
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):443-51. PubMed ID: 22560893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo.
    Zheng H; Wen S; Zhang Y; Sun Z
    PLoS One; 2015; 10(10):e0140265. PubMed ID: 26451735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotides.
    Zhang H; Yamazaki T; Zhi C; Hanagata N
    Nanoscale; 2012 Oct; 4(20):6343-50. PubMed ID: 22941279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chitosan nanoparticles fabricated through host-guest interaction for enhancing the immunostimulatory effect of CpG oligodeoxynucleotide.
    Wang Z; van Drunen Littel-van den Hurk S; Chen L
    Carbohydr Polym; 2021 Nov; 271():118417. PubMed ID: 34364558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
    Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
    ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
    Zhang H; Feng S; Yan T; Zhi C; Gao XD; Hanagata N
    Int J Nanomedicine; 2015; 10():5343-53. PubMed ID: 26346655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy.
    Deng Z; Zhen Z; Hu X; Wu S; Xu Z; Chu PK
    Biomaterials; 2011 Jul; 32(21):4976-86. PubMed ID: 21486679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase.
    Wang S; Han Q; Zhang G; Zhang N; Li Z; Chen J; Lv Y; Li N; Xing F; Tian N; Zhu Q; Liu Z
    Int Immunopharmacol; 2011 Apr; 11(4):406-11. PubMed ID: 21182997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
    Di JM; Pang J; Pu XY; Zhang Y; Liu XP; Fang YQ; Ruan XX; Gao X
    Cancer Genet Cytogenet; 2009 Jul; 192(2):60-7. PubMed ID: 19596255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of inorganic/organic ratio and chemical coupling on the performance of porous silica/chitosan hybrid scaffolds.
    Wang D; Liu W; Feng Q; Dong C; Liu Q; Duan L; Huang J; Zhu W; Li Z; Xiong J; Liang Y; Chen J; Sun R; Bian L; Wang D
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):969-975. PubMed ID: 27772728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesostructured chitosan-silica hybrid as a biodegradable carrier for a pH-responsive drug delivery system.
    Zheng H; Huang Z; Che S
    Dalton Trans; 2012 Apr; 41(16):5038-44. PubMed ID: 22378252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9.
    Shimosato T; Fujimoto M; Tohno M; Sato T; Tateo M; Otani H; Kitazawa H
    Biochem Biophys Res Commun; 2010 Mar; 394(1):81-6. PubMed ID: 20178773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.